BAM
Bruderman Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-98,772
| Closed | -$5.84M | – | 107 |
|
|
2021
Q3 | $5.84M | Sell |
98,772
-46,616
| -32% | -$2.76M | 1.47% | 21 |
|
|
2021
Q2 | $9.72M | Buy |
145,388
+1,505
| +1% | +$101K | 3.01% | 11 |
|
|
2021
Q1 | $9.08M | Buy |
143,883
+3,186
| +2% | +$201K | 2.52% | 10 |
|
|
2020
Q4 | $8.73M | Buy |
140,697
+5,333
| +4% | +$331K | 2.53% | 9 |
|
|
2020
Q3 | $8.16M | Buy |
135,364
+58,108
| +75% | +$3.5M | 2.68% | 7 |
|
|
2020
Q2 | $4.59M | Buy |
77,256
+1,259
| +2% | +$74.8K | 1.52% | 25 |
|
|
2020
Q1 | $4.17M | Sell |
75,997
-1,708
| -2% | -$93.6K | 1.65% | 20 |
|
|
2019
Q4 | $4.92M | Sell |
77,705
-6,120
| -7% | -$388K | 1.54% | 24 |
|
|
2019
Q3 | $4.86M | Buy |
+83,825
| New | +$4.86M | 1.23% | 29 |
|
|
2019
Q2 | – | Sell |
-4,009
| Closed | -$191K | – | 166 |
|
|
2019
Q1 | $191K | Sell |
4,009
-129
| -3% | -$6.15K | 0.04% | 133 |
|
|
2018
Q4 | $215K | Buy |
+4,138
| New | +$215K | 0.06% | 121 |
|
|
2017
Q1 | – | Sell |
-3,522
| Closed | -$206K | – | 140 |
|
|
2016
Q4 | $206K | Sell |
3,522
-1,100
| -24% | -$64.3K | 0.06% | 107 |
|
|
2016
Q3 | $249K | Buy |
4,622
+364
| +9% | +$19.6K | 0.07% | 107 |
|
|
2016
Q2 | $313K | Buy |
4,258
+15
| +0.4% | +$1.1K | 0.1% | 101 |
|
|
2016
Q1 | $271K | Buy |
4,243
+17
| +0.4% | +$1.09K | 0.09% | 102 |
|
|
2015
Q4 | $291K | Sell |
4,226
-1,500
| -26% | -$103K | 0.11% | 99 |
|
|
2015
Q3 | $339K | Buy |
5,726
+248
| +5% | +$14.7K | 0.13% | 84 |
|
|
2015
Q2 | $365K | Buy |
5,478
+209
| +4% | +$13.9K | 0.14% | 84 |
|
|
2015
Q1 | $340K | Buy |
+5,269
| New | +$340K | 0.13% | 85 |
|